Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS)
CNY 42.07
(-0.45%)
CNY 42.07
(-0.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.18 Billion | 3.64 Billion | 3.27 Billion | 2.45 Billion | 2.23 Billion | 2.16 Billion |
| Cost of Revenue | 2.3 Billion | 2.06 Billion | 1.85 Billion | 1.45 Billion | 1.34 Billion | 1.4 Billion |
| Gross Profit | 1.88 Billion | 1.57 Billion | 1.42 Billion | 998.09 Million | 894.2 Million | 753.37 Million |
| Operating Expenses | 1.56 Billion | 1.24 Billion | 1.17 Billion | 936.62 Million | 841.84 Million | 714.85 Million |
| Selling, General and Administrative Expenses | 1.5 Billion | 1.1 Billion | 1.02 Billion | 811.05 Million | 718.57 Million | 590.58 Million |
| Research and Development Expenses | 75.39 Million | 73.19 Million | 52.61 Million | 37.4 Million | 41.01 Million | 25.62 Million |
| Other Expenses | 2.44 Million | 71.5 Million | 103.45 Million | 88.16 Million | 82.26 Million | 98.64 Million |
| Cost and Expenses | 3.63 Billion | 3.31 Billion | 3.02 Billion | 2.39 Billion | 2.18 Billion | 2.12 Billion |
| Operating Income | 573.86 Million | 442.17 Million | 365.23 Million | 160.81 Million | 105.03 Million | 93.89 Million |
| Interest Expense | 4.82 Million | 4.8 Million | 3.24 Million | 547.61 Thousand | 666.22 Thousand | 579.41 Thousand |
| Income Tax Expense | 47.85 Million | 32.43 Million | 35.51 Million | 8.92 Million | 7.16 Million | 6.68 Million |
| Earnings before Tax | 571.09 Million | 437.94 Million | 360.93 Million | 157.6 Million | 99.79 Million | 87.98 Million |
| Net Income | 521.45 Million | 408.08 Million | 305.25 Million | 147.78 Million | 91.49 Million | 81.21 Million |
| Earnings Per Share Basic | 3.41 | 2.68 | 2.01 | 0.96 | 0.60 | 0.53 |
| Earnings Per Share Diluted | 3.41 | 2.68 | 2.01 | 0.96 | 0.60 | 0.53 |
| Weighted Average Shares Outstanding | 152.92 Million | 152.49 Million | 151.86 Million | 153.31 Million | 153.39 Million | 153.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 152.92 Million | 152.49 Million | 151.86 Million | 153.31 Million | 153.39 Million | 153.24 Million |
| Gross Margin | 0.45 | 0.43 | 0.43 | 0.41 | 0.40 | 0.35 |
| EBIT Margin | 0.15 | 0.14 | 0.12 | 0.07 | 0.06 | 0.05 |
| Profit Margin | 0.12 | 0.11 | 0.09 | 0.06 | 0.04 | 0.04 |
| EBITDA | 615.11 Million | 481.57 Million | 288.23 Million | 178.85 Million | 120 Million | 108.46 Million |
| Earnings Before Tax Margin | 0.14 | 0.12 | 0.11 | 0.07 | 0.05 | 0.04 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 871.72 Million | 1.03 Billion | 964.77 Million | 1.08 Billion | 4.18 Billion | 956.18 Million |
| Cost of Revenue | 496.76 Million | 594.1 Million | 557.82 Million | 637.67 Million | 2.3 Billion | 487.56 Million |
| Gross Profit | 374.95 Million | 438.51 Million | 406.94 Million | 450.98 Million | 1.88 Billion | 468.62 Million |
| Operating Expenses | 345.3 Million | 382.44 Million | 369.32 Million | 397.83 Million | 1.56 Billion | 376.09 Million |
| Selling, General and Administrative Expenses | 479.6 Million | 366.48 Million | 346.37 Million | 361.08 Million | - | 432.68 Million |
| Research and Development Expenses | 19.97 Million | 15.95 Million | 22.95 Million | 21.46 Million | - | 16.86 Million |
| Other Expenses | -154.27 Million | -1.7 Million | -1.36 Million | -15.27 Million | 2.44 Million | -14.61 Million |
| Cost and Expenses | 842.06 Million | 976.55 Million | 927.15 Million | 1.03 Billion | 3.87 Billion | 863.65 Million |
| Operating Income | 89.1 Million | 56.07 Million | 37.62 Million | 53.15 Million | 312.67 Million | 176.05 Million |
| Interest Expense | 6.94 Million | 1.31 Million | 1.3 Million | 1.43 Million | 4.82 Million | 1.36 Million |
| Income Tax Expense | 3.7 Million | 11.51 Million | 8.04 Million | 5.39 Million | 47.85 Million | 12.55 Million |
| Earnings before Tax | 87.23 Million | 97.31 Million | 47.61 Million | 74.46 Million | 385.88 Million | 176.01 Million |
| Net Income | 82.25 Million | 139.83 Million | 99.52 Million | 106.33 Million | 521.45 Million | 162.75 Million |
| Earnings Per Share Basic | 0.54 | 0.91 | 0.65 | 0.70 | - | 1.07 |
| Earnings Per Share Diluted | 0.54 | 0.91 | 0.65 | 0.70 | - | 1.07 |
| Weighted Average Shares Outstanding | 153.39 Million | 153.21 Million | 153 Million | 153 Million | 152.92 Million | 152.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 153.39 Million | 153.21 Million | 153 Million | 153 Million | 152.92 Million | 152.81 Million |
| Gross Margin | 0.43 | 0.42 | 0.42 | 0.41 | 0.45 | 0.49 |
| EBIT Margin | 0.11 | 0.07 | 0.11 | 0.06 | - | 0.16 |
| Profit Margin | 0.09 | 0.14 | 0.10 | 0.10 | 0.12 | 0.17 |
| EBITDA | 94.17 Million | 72.41 Million | 102.01 Million | 69.82 Million | - | 155.69 Million |
| Earnings Before Tax Margin | 0.10 | 0.05 | 0.04 | 0.05 | 0.07 | 0.18 |
KIRANSY-B
9830
603341
NELCAST
SEMG
EGL